In vitro response of v-Ha-ras transgenic mouse lymphocytes after in vivo treatment with cocaine.
Oncomouse is a transgenic mouse carrying an activated v-Ha-ras oncogene under the control of the mouse mammary tumor virus promoter. The objective of this paper was to learn if the in vitro secretion of IL-2 and IFN-gamma and the release of sIL-2R by Oncomice spleen and thymus cells depended on the presence of the oncogene product, on the in vivo pretreatment with cocaine, or on the in vitro treatment with cocaine or morphine. Oncomice thymocytes from different experimental groups released less sIL-2R than FVB thymocytes. Oncomice thymocytes secreted more IFN-gamma than FVB thymocytes. Oncomice thymocytes cultured in the presence of Con A and cocaine showed a diminished release of sIL-2R and a lower secretion of IFN-gamma, a phenomenon not observed in FVB thymocytes. IFN-gamma secretion was lower in Oncomice splenocytes. In general, Oncomice thymocytes and splenocytes responded in a nearly opposite fashion to their FVB counterparts. In this study, the in vitro response to mitogens, cocaine or morphine depended on genetic background and not on the in vivo pretreatment with cocaine. Our results emphasize the role of the v-Ha-ras oncogene in defining the host immune response.
Colombo
L L
LL
Health Promotion Sciences, College of Public Health, University of Arizona, Tucson 85724, USA.
López
M C
MC
Chen
G
G
Watson
R R
RR
D000818:Animals; D003042:Cocaine / Q000633:toxicity*; D004797:Enzyme-Linked Immunosorbent Assay; D005260:Female; D011905:Genes, ras; D066298:In Vitro Techniques; D007274:Injections, Intraperitoneal; D007371:Interferon-gamma / Q000096:biosynthesis / Q000187:drug effects; D007376:Interleukin-2 / Q000096:biosynthesis; D008213:Lymphocyte Activation / Q000187:drug effects* / Q000235:genetics; D008214:Lymphocytes / Q000187:drug effects* / Q000378:metabolism; D051379:Mice; D008815:Mice, Inbred Strains; D008822:Mice, Transgenic; D009020:Morphine / Q000633:toxicity; D013154:Spleen / Q000187:drug effects / Q000378:metabolism / Q000473:pathology; D013950:Thymus Gland / Q000187:drug effects / Q000378:metabolism / Q000473:pathology
D007376:Interleukin-2; D009020:Morphine; D007371:Interferon-gamma; D003042:Cocaine